Evidence map›Paper›PMID 38102139›Full record

ArticleNature communications2023

The function of ER-phagy receptors is regulated through phosphorylation-dependent ubiquitination pathways.

Rayene Berkane, Hung Ho-Xuan, Marius Glogger, Pablo Sanz-Martinez, Lorène Brunello, Tristan Glaesner, Santosh Kumar Kuncha, Katharina Holzhüter, Sara Cano-Franco, Viviana Buonomo and 11 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 34 citations in OpenAlex.

  1. Review
  2. Review
  3. Regulation and roles of mammalian mitophagy.Nature reviews. Molecular cell biology · 2026
    Review
  4. Selective autophagy in kidney health and disease.Nature reviews. Nephrology · 2026
    Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 4 institutions in 2 countries.

Rayene BerkaneInstitute of Biochemistry II (IBC2), Faculty of Medicine, Goethe University, Frankfurt am Main, Germany.ORCID 0000-0002-0705-2298
Hung Ho-Xuan *Institute of Biochemistry II (IBC2), Faculty of Medicine, Goethe University, Frankfurt am Main, Germany.ORCID 0000-0003-2911-1559
Marius Glogger *Institute of Physical and Theoretical Chemistry, Goethe University, Frankfurt am Main, Germany.ORCID 0000-0003-2834-2785
Pablo Sanz-Martinez *Institute of Biochemistry II (IBC2), Faculty of Medicine, Goethe University, Frankfurt am Main, Germany.
Lorène BrunelloInstitute of Biochemistry II (IBC2), Faculty of Medicine, Goethe University, Frankfurt am Main, Germany.ORCID 0000-0001-7222-3033
Tristan GlaesnerBuchmann Institute for Molecular Life Sciences (BMLS), Goethe University, Frankfurt am Main, Germany.
Santosh Kumar KunchaInstitute of Biochemistry II (IBC2), Faculty of Medicine, Goethe University, Frankfurt am Main, Germany.ORCID 0000-0002-2538-8342
Katharina HolzhüterInstitute of Biophysical Chemistry and Center for Biomolecular Magnetic Resonance, Goethe University, Frankfurt am Main, Germany.ORCID 0000-0002-8411-347X
Sara Cano-FrancoInstitute of Biochemistry II (IBC2), Faculty of Medicine, Goethe University, Frankfurt am Main, Germany.
Viviana BuonomoTelethon Institute of Genetics and Medicine (TIGEM), Pozzuoli, Italy.
Paloma Cabrerizo-PovedaInstitute of Biochemistry II (IBC2), Faculty of Medicine, Goethe University, Frankfurt am Main, Germany.ORCID 0009-0009-8015-1979
Ashwin BalakrishnanInstitute of Physical and Theoretical Chemistry, Goethe University, Frankfurt am Main, Germany.ORCID 0000-0003-4059-8345
Georg TascherInstitute of Biochemistry II (IBC2), Faculty of Medicine, Goethe University, Frankfurt am Main, Germany.ORCID 0000-0002-5907-3947
Koraljka HusnjakInstitute of Biochemistry II (IBC2), Faculty of Medicine, Goethe University, Frankfurt am Main, Germany.ORCID 0000-0003-0573-6239
Thomas JuretschkeInstitute of Molecular Biology, Mainz, Germany.
Mohit MisraInstitute of Biochemistry II (IBC2), Faculty of Medicine, Goethe University, Frankfurt am Main, Germany.
Alexis GonzálezInstitute of Biochemistry II (IBC2), Faculty of Medicine, Goethe University, Frankfurt am Main, Germany.ORCID 0000-0003-3741-6854
Volker DötschInstitute of Biophysical Chemistry and Center for Biomolecular Magnetic Resonance, Goethe University, Frankfurt am Main, Germany.ORCID 0000-0001-5720-212X
Paolo GrumatiTelethon Institute of Genetics and Medicine (TIGEM), Pozzuoli, Italy.ORCID 0000-0002-9942-9389
Mike HeilemannInstitute of Physical and Theoretical Chemistry, Goethe University, Frankfurt am Main, Germany.ORCID 0000-0002-9821-3578
Alexandra StolzInstitute of Biochemistry II (IBC2), Faculty of Medicine, Goethe University, Frankfurt am Main, Germany. stolz@em.uni-frankfurt.de.ORCID 0000-0002-3340-439X
Goethe University Frankfurt · DEFederico II University Hospital · ITInstitute of Molecular Biology · DETelethon Institute Of Genetics And Medicine · IT

Funding

Deutsche Forschungsgemeinschaft (German Research Foundation) 259130777Deutsche Forschungsgemeinschaft (German Research Foundation) 259130777, 512574446, 515275293, 403765277Fondazione Telethon (Telethon Foundation) TMPGMFU22TT
6 · The paper itself

Abstract

Selective autophagy of the endoplasmic reticulum (ER), known as ER-phagy, is an important regulator of ER remodeling and essential to maintain cellular homeostasis during environmental changes. We recently showed that members of the FAM134 family play a critical role during stress-induced ER-phagy. However, the mechanisms on how they are activated remain largely unknown. In this study, we analyze phosphorylation of FAM134 as a trigger of FAM134-driven ER-phagy upon mTOR (mechanistic target of rapamycin) inhibition. An unbiased screen of kinase inhibitors reveals CK2 to be essential for FAM134B- and FAM134C-driven ER-phagy after mTOR inhibition. Furthermore, we provide evidence that ER-phagy receptors are regulated by ubiquitination events and that treatment with E1 inhibitor suppresses Torin1-induced ER-phagy flux. Using super-resolution microscopy, we show that CK2 activity is essential for the formation of high-density FAM134B and FAM134C clusters. In addition, dense clustering of FAM134B and FAM134C requires phosphorylation-dependent ubiquitination of FAM134B and FAM134C. Treatment with the CK2 inhibitor SGC-CK2-1 or mutation of FAM134B and FAM134C phosphosites prevents ubiquitination of FAM134 proteins, formation of high-density clusters, as well as Torin1-induced ER-phagy flux. Therefore, we propose that CK2-dependent phosphorylation of ER-phagy receptors precedes ubiquitin-dependent activation of ER-phagy flux.

Indexed as

AutophagyMembrane ProteinsCarrier ProteinsEndoplasmic ReticulumEndoplasmic Reticulum StressPhosphorylationTOR Serine-Threonine KinasesUbiquitinationCarrier ProteinsMembrane ProteinsTOR Serine-Threonine Kinases

Identifiers

PMID38102139
PMCPMC10724265
OpenAlexW4389783917

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.